Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Rosen Law Firm Sues Aquestive Therapeutics
Regulatory class action lawsuit

Rosen Law Firm Sues Aquestive Therapeutics

Analysis based on 52 articles · First reported Mar 10, 2026 · Last updated Apr 14, 2026

Sentiment
-20
Attention
2
Articles
52
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard
Market Impact

The class action lawsuit against Aquestive Therapeutics is likely to negatively impact its stock price on Nasdaq due to potential financial liabilities and damage to its reputation. Investors who purchased Aquestive Therapeutics securities during the Class Period may be entitled to compensation.

Pharmaceuticals Legal Services
Event Summary

Rosen Law Firm has announced a class action lawsuit against Aquestive Therapeutics, reminding investors of the lead plaintiff deadline of May 4, 2026. The lawsuit alleges that Aquestive Therapeutics made false and misleading statements and/or failed to disclose the true state of its New Drug Application (NDA) for Aquestive Therapeutics===Anaphylm. Specifically, the company is accused of concealing or minimizing the significance of human factors related to the use and deployment of its sublingual film, including packaging, administration, and labeling. Investors who purchased Aquestive Therapeutics securities between June 16, 2025, and January 8, 2026, are encouraged to join the class action to seek compensation for damages suffered when the true details of the NDA became known.

Key Actions
100 Rosen Law Firm filed class action lawsuit Aquestive Therapeutics
90 Aquestive Therapeutics made false/misleading statements regarding Aquestive Therapeutics===Anaphylm NDA
90 Aquestive Therapeutics made allegedly false/misleading statements
90 Aquestive Therapeutics allegedly made false/misleading statements
Entities Involved
stock
Aquestive Therapeutics
Aquestive Therapeutics is facing a class action lawsuit for allegedly making false and misleading statements regarding its New Drug Application for Aquestive Therapeutics===Anaphylm. This could lead to financial penalties and reputational damage for the company.
Importance 100 Sentiment -50
priv
Rosen Law Firm
Rosen Law Firm is initiating and representing investors in the class action lawsuit against Aquestive Therapeutics, aiming to secure compensation for affected shareholders. This action enhances their reputation as a leading investor rights law firm.
Importance 80 Sentiment 70
govactor
United States===Food and Drug Administration
The U.S. Food and Drug Administration (FDA) identified deficiencies in Aquestive Therapeutics' New Drug Application for Aquestive Therapeutics===Anaphylm, which led to the indefinite delay of the drug's approval and subsequently impacted Aquestive Therapeutics' stock price.
Importance 80 Sentiment 0
subs
Aquestive Therapeutics===Anaphylm
Aquestive Therapeutics===Anaphylm is the subject of the New Drug Application that Aquestive Therapeutics allegedly misrepresented. Issues with its human factors in use and deployment are central to the lawsuit.
Importance 70 Sentiment -50
priv
Pomerantz LLP
Pomerantz LLP filed the class action lawsuit against Aquestive Therapeutics, representing investors who suffered losses. The firm specializes in corporate, securities, and antitrust class litigation.
Importance 70 Sentiment 20
subs
Aquestive Therapeutics===Anaphylm
Aquestive Therapeutics===Anaphylm is the product at the center of the lawsuit against Aquestive Therapeutics, with allegations of undisclosed issues regarding its New Drug Application. The legal proceedings could impact its future market prospects.
Importance 60 Sentiment -30
exch
Nasdaq
Nasdaq is the stock exchange where Aquestive Therapeutics' securities are traded. The lawsuit may cause fluctuations in the stock price listed on Nasdaq.
Importance 10 Sentiment 0
Relationships
Aquestive Therapeutics related ↔ Rosen Law Firm
Rosen Law Firm related ↔ Aquestive Therapeutics
Aquestive Therapeutics related ↔ Aquestive Therapeutics===Anaphylm
Rosen Law Firm related ↔ Aquestive Therapeutics===Anaphylm
Aquestive Therapeutics related ↔ Pomerantz LLP
Aquestive Therapeutics related ↔ United States===Food and Drug Administration
Pomerantz LLP related ↔ United States===Food and Drug Administration
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.